A Study of KITE-753 in People With Large B-Cell Lymphoma

Full Title

A Phase 3, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants with Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Gunjan Shah’s office at 646-608-2091.

Protocol
26-297
Phase
Phase III (phase 3)
Investigator
Gunjan L. Shah
Co-Investigators
Jennifer K. Lue
Diseases
Lymphoma › Non-Hodgkin's Lymphoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07479797
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description